Venmax Drugs

{
  "main_header": {
    "sid": 225982,
    "name": "Venmax Drugs",
    "stock_name": "Venmax Drugs",
    "full_name": "Venmax Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/venmax-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "25.23",
    "chg": -1.32,
    "chgp": "-4.97%",
    "dir": -1,
    "prev_price": "26.55",
    "mcapval": "20.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531015,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE154G01022",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "1.85 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venmax-drugs-225982-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Venmax Drugs & Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-pharmaceuticals-ltd-fallingrising-3783682",
        "imagepath": "",
        "date": "2026-01-07 02:29:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Intraday Volatility and Price Movements</strong></p>\n<p>On the trading day of 06-Jan, Venmax Drugs &amp; Pharmaceuticals Ltd opened with a gap down of 4.98%, signalling initial bearish sentiment among investors. However, the stock demonstrated resilience by recovering to touch an intraday high of ₹26.97, representing a 4.9% gain from its previous close. The day's trading range was wide, spanning ₹2.54, with the stock dipping to a low of ₹24.43 before rallying. This volatility indicates active trading interest and a tug-of-war between buyers and sellers throughout the session.</p>\n<p><strong>Volume and Investor Participation Trends</strong></p>\n<p>Despite the price recovery, investor participation appears to be waning. Delivery volume on 05 Jan stood at 1.1 lakh shares, which is a sharp decli..."
      },
      {
        "title": "How has been the historical performance of Venmax Drugs?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-venmax-drugs-3695032",
        "imagepath": "",
        "date": "2025-11-13 00:04:45",
        "description": "Answer:\nThe historical performance of Venmax Drugs shows significant fluctuations in its financial metrics over the years, particularly in net sales, operating profit, and overall profitability.\n\nBreakdown:\nVenmax Drugs reported net sales of 0.81 Cr in March 2025, a notable increase from 0.00 Cr in March 2024, but still below the 2.55 Cr recorded in March 2015. The total operating income followed a similar trend, reaching 0.81 Cr in March 2025, compared to 0.00 Cr in the previous year. However, total expenditure surged to 1.86 Cr in March 2025, up from 0.10 Cr in March 2024, leading to an operating profit (PBDIT) of 0.00 Cr in March 2025, a decline from 0.10 Cr in March 2024. The profit before tax was slightly negative at -0.01 Cr in March 2025, contrasting with a profit of 0.09 Cr in March 2024. Consequently, the profit after tax also fell to -0.01 Cr in March 2025 from 0.06 Cr in March 2024. The company's..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3667603",
        "imagepath": "",
        "date": "2025-11-03 21:22:40",
        "description": "As of 03-Nov, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 28.70, reflecting a change of 0.7 or 2.5% upward. The stock has shown strong performance recently, gaining 10.09% over the last three days and outperforming its sector by 1.2% today. Additionally, over the past month, the stock has surged by 42.43%, significantly outpacing the Sensex, which has only increased by 3.41%. However, it is important to note that there has been a notable decline in investor participation, with delivery volume dropping by 77.96% against the five-day average, which may indicate a potential concern regarding sustained interest in the stock.\n\nIn the broader market context, Venmax Drugs has outperformed the Sensex over the past week, with a return of 1.59% compared to the benchmark's decline of 0.94%. Year-to-date, the stock has also significantly outperformed the Sensex, achieving a return ..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3653463",
        "imagepath": "",
        "date": "2025-10-28 23:45:51",
        "description": "As of 28-Oct, Venmax Drugs & Pharmaceuticals Ltd is currently priced at 27.88, reflecting a decrease of 0.37, or 1.31%. The stock has been underperforming its sector, with a performance today that is down by 1.05%. It has experienced consecutive declines over the last two days, resulting in a total drop of 6.16%. Despite this recent downturn, the stock has shown strong performance over the past month, with a return of 25.93%, and a year-to-date increase of 54.55%. Additionally, Venmax is trading above its moving averages across various time frames, indicating a generally positive trend prior to the recent falls. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Venmax's short-term performance over the past week has outpaced the benchmark Sensex, which has only increased by 0.24%, while Venmax has r..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3644644",
        "imagepath": "",
        "date": "2025-10-24 21:28:51",
        "description": "As of 24-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 29.71, reflecting a rise of Rs 1.31 or 4.61%. The stock has shown strong performance, gaining 48.85% over the last nine days and outperforming its sector by 5% today. It opened with a 5% gain and reached an intraday high of Rs 29.82. Additionally, the stock is trading above its moving averages across various time frames, indicating a bullish trend. The recent increase in delivery volume, which rose by 69.77% against the five-day average, suggests rising investor participation, contributing positively to the stock's momentum. There are no positive or negative factors explicitly mentioned that could impact the stock's recent movement.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has only increased by 0.31% over the past week, Venmax Drugs has significantly outperformed with ..."
      }
    ],
    "total": 73,
    "sid": "225982",
    "stock_news_url": "https://www.marketsmojo.com/news/venmax-drugs-pharmaceuticals-225982"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "Intimation of Closure of Trading Window for the Quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "25-Nov-2025",
      "details": "The board has considered and accepted the Resignation of Mrs . Dakshita Jain as Non Executive Independent Director of the company w.e.f. November 24 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Venmax Drugs & Pharmaceuticals Ltd falling/rising?

2026-01-07 02:29:49

Intraday Volatility and Price Movements

On the trading day of 06-Jan, Venmax Drugs & Pharmaceuticals Ltd opened with a gap down of 4.98%, signalling initial bearish sentiment among investors. However, the stock demonstrated resilience by recovering to touch an intraday high of ₹26.97, representing a 4.9% gain from its previous close. The day's trading range was wide, spanning ₹2.54, with the stock dipping to a low of ₹24.43 before rallying. This volatility indicates active trading interest and a tug-of-war between buyers and sellers throughout the session.

Volume and Investor Participation Trends

Despite the price recovery, investor participation appears to be waning. Delivery volume on 05 Jan stood at 1.1 lakh shares, which is a sharp decli...

Read full news article

How has been the historical performance of Venmax Drugs?

2025-11-13 00:04:45

Answer: The historical performance of Venmax Drugs shows significant fluctuations in its financial metrics over the years, particularly in net sales, operating profit, and overall profitability. Breakdown: Venmax Drugs reported net sales of 0.81 Cr in March 2025, a notable increase from 0.00 Cr in March 2024, but still below the 2.55 Cr recorded in March 2015. The total operating income followed a similar trend, reaching 0.81 Cr in March 2025, compared to 0.00 Cr in the previous year. However, total expenditure surged to 1.86 Cr in March 2025, up from 0.10 Cr in March 2024, leading to an operating profit (PBDIT) of 0.00 Cr in March 2025, a decline from 0.10 Cr in March 2024. The profit before tax was slightly negative at -0.01 Cr in March 2025, contrasting with a profit of 0.09 Cr in March 2024. Consequently, the profit after tax also fell to -0.01 Cr in March 2025 from 0.06 Cr in March 2024. The company's...

Read full news article

Why is Venmax Drugs falling/rising?

2025-11-03 21:22:40

As of 03-Nov, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 28.70, reflecting a change of 0.7 or 2.5% upward. The stock has shown strong performance recently, gaining 10.09% over the last three days and outperforming its sector by 1.2% today. Additionally, over the past month, the stock has surged by 42.43%, significantly outpacing the Sensex, which has only increased by 3.41%. However, it is important to note that there has been a notable decline in investor participation, with delivery volume dropping by 77.96% against the five-day average, which may indicate a potential concern regarding sustained interest in the stock. In the broader market context, Venmax Drugs has outperformed the Sensex over the past week, with a return of 1.59% compared to the benchmark's decline of 0.94%. Year-to-date, the stock has also significantly outperformed the Sensex, achieving a return ...

Read full news article

Why is Venmax Drugs falling/rising?

2025-10-28 23:45:51

As of 28-Oct, Venmax Drugs & Pharmaceuticals Ltd is currently priced at 27.88, reflecting a decrease of 0.37, or 1.31%. The stock has been underperforming its sector, with a performance today that is down by 1.05%. It has experienced consecutive declines over the last two days, resulting in a total drop of 6.16%. Despite this recent downturn, the stock has shown strong performance over the past month, with a return of 25.93%, and a year-to-date increase of 54.55%. Additionally, Venmax is trading above its moving averages across various time frames, indicating a generally positive trend prior to the recent falls. There is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Venmax's short-term performance over the past week has outpaced the benchmark Sensex, which has only increased by 0.24%, while Venmax has r...

Read full news article

Why is Venmax Drugs falling/rising?

2025-10-24 21:28:51

As of 24-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 29.71, reflecting a rise of Rs 1.31 or 4.61%. The stock has shown strong performance, gaining 48.85% over the last nine days and outperforming its sector by 5% today. It opened with a 5% gain and reached an intraday high of Rs 29.82. Additionally, the stock is trading above its moving averages across various time frames, indicating a bullish trend. The recent increase in delivery volume, which rose by 69.77% against the five-day average, suggests rising investor participation, contributing positively to the stock's momentum. There are no positive or negative factors explicitly mentioned that could impact the stock's recent movement. Broader Market Context: In comparison to the benchmark Sensex, which has only increased by 0.31% over the past week, Venmax Drugs has significantly outperformed with ...

Read full news article

View All News